SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?


To: Jibacoa who wrote (1118)6/20/2005 10:51:07 PM
From: Galirayo  Respond to of 3722
 
Actually .. that's what I was thinking Bernard ...

But I did and Edit on the last post .. The candle bodies there on the April 04 will .. IMHO .. be the R .. not the Highs. If it carries the Bodies the The Highs are "usually" a done deal. I think it's got it.

Check this Weekly Aroon Cross over for Trend.
stockcharts.com[w,a]wacayiay[de][pb50!c20!f][vc60][iut!Ua12,26,9!Uv25]&pref=G

My Guess ... It'll Rock.



To: Jibacoa who wrote (1118)6/20/2005 10:56:43 PM
From: Jibacoa  Read Replies (2) | Respond to of 3722
 
REGN Continued on its near term Uptrend that started on June 14 from the 6.18 level. It was up almost 13% at the close after it traded as H as 8.82 and the volume although less than Friday's still was more than 800 Ks.(more than double its average.) The stock was still trading higher AHs.

bigcharts.marketwatch.com

The results for the March Q were not good with revenues down to 16.2M and earnings of of $0.02/shr vs. $1.06 in 2004 REGN is expected to show a loss for 2005 of $1.80 and $1.90 in 2006 <g>

However, it reportedly has around $6 in cash/shr and is CF & FCF +

It has a pretty good pipeline including product candidates for Ca, RA,allergies, asthma, obesity,opthalmologic conditions and others
It has some collaboration agreements with some of the large Cos.

Bernard